Holen Sie sich die Stockscreener-App
81.79
2.93%
2.33
Vorhandelsmarkt:
82.42
0.63
+0.77%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTVA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$79.46
Offen:
$80.24
24-Stunden-Volumen:
4.65M
Relative Volume:
1.14
Marktkapitalisierung:
$54.57B
Einnahmen:
$17.89B
Nettoeinkommen (Verlust:
$1.26B
KGV:
48.03
EPS:
1.7029
Netto-Cashflow:
$2.05B
1W Leistung:
+6.66%
1M Leistung:
-5.92%
6M Leistung:
+7.18%
1J Leistung:
+12.07%
1-Tages-Spanne:
$79.45
$82.15
1-Wochen-Bereich:
$75.47
$82.15
52-Wochen-Spanne:
$60.53
$90.97
Corteva Inc Stock (CTVA) Company Profile
Firmenname
Corteva Inc
Sektor
Branche
Telefon
(833) 267-8382
Adresse
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Compare CTVA vs NTR, CF, MOS, ICL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTVA
Corteva Inc
|
81.79 | 53.02B | 17.89B | 1.26B | 2.05B | 1.7029 |
NTR
Nutrien Ltd
|
75.27 | 34.89B | 27.83B | 2.42B | 2.21B | 4.9113 |
CF
Cf Industries Holdings Inc
|
129.60 | 19.02B | 7.41B | 2.12B | 1.62B | 11.13 |
MOS
Mosaic Company
|
24.41 | 7.42B | 12.43B | 70.90M | -489.30M | 0.1275 |
ICL
Icl Group Ltd
|
5.80 | 7.12B | 7.41B | 314.00M | 220.88M | 0.202 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Herabstufung | UBS | Buy → Neutral |
| 2026-02-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-10-03 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-10-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-10-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-08-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2025-03-13 | Eingeleitet | Goldman | Buy |
| 2024-10-23 | Eingeleitet | Citigroup | Buy |
| 2024-10-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-07 | Herabstufung | Argus | Buy → Hold |
| 2024-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-03-01 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-12 | Hochstufung | Loop Capital | Hold → Buy |
| 2024-02-02 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2023-11-27 | Herabstufung | Berenberg | Buy → Hold |
| 2023-11-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-10-20 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-09-05 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-25 | Herabstufung | Redburn | Buy → Neutral |
| 2023-06-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Hochstufung | Vertical Research | Hold → Buy |
| 2023-04-06 | Eingeleitet | Oppenheimer | Perform |
| 2023-01-19 | Eingeleitet | Wells Fargo | Overweight |
| 2023-01-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-11-16 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-15 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-08-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2022-07-14 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-01 | Eingeleitet | Barclays | Overweight |
| 2022-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-14 | Hochstufung | Loop Capital | Hold → Buy |
| 2022-04-14 | Herabstufung | Vertical Research | Buy → Hold |
| 2022-01-31 | Hochstufung | Redburn | Neutral → Buy |
| 2021-10-18 | Herabstufung | Loop Capital | Buy → Hold |
| 2021-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-09-01 | Eingeleitet | Berenberg | Buy |
| 2021-08-09 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
| 2021-05-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-04-19 | Hochstufung | Loop Capital | Hold → Buy |
| 2021-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-02-05 | Bestätigt | Monness Crespi & Hardt | Sell |
| 2020-12-18 | Herabstufung | Susquehanna | Positive → Neutral |
| 2020-12-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-10 | Hochstufung | Argus | Hold → Buy |
| 2020-10-19 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-19 | Herabstufung | Exane BNP Paribas | Outperform → Underperform |
| 2020-08-11 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-08-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-06-26 | Eingeleitet | Cleveland Research | Neutral |
| 2020-06-16 | Hochstufung | Vertical Research | Hold → Buy |
| 2020-06-08 | Herabstufung | Monness Crespi & Hardt | Neutral → Sell |
| 2020-05-11 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-04-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-04-17 | Hochstufung | Loop Capital | Sell → Hold |
| 2020-04-01 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-31 | Hochstufung | Susquehanna | Neutral → Positive |
| 2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-19 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-03-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-03-10 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
Alle ansehen
Corteva Inc Aktie (CTVA) Neueste Nachrichten
Corteva’s Field Trials Didn’t Undermine Its Seed-Patent Rights - Bloomberg Law News
Vylor Sells $1.1B Bonds for Corteva Spinoff - Briefs Finance
Corteva and EIDP Announce Fourth Supplemental Indenture Amid Planned Corporate Split - Kalkine Media
Corteva Inc. stock outperforms competitors on strong trading day - MarketWatch
CTVA Looks 20.3% Overvalued on GF Value™ Amid $1.1B Bond Offerin - GuruFocus
Top Agriculture Stocks To ResearchAugust 20th - MarketBeat
Corteva spinoff Vylor launches $1.1B bond sale to fund parent payout (CTVA:NYSE) - Seeking Alpha
Corteva, Inc. (CTVA) Files Form 8-K with Press Release on August 20, 2026 - GuruFocus
Corteva Announces Early Tender Results And Extension Of Expiration Date In Private Exchange Offers And Consent Solicitations For Eidp's 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 And 4.800% Senior Notes Due 2033 - TradingView
Corteva Announces Early Tender Results and Extension of Expiration Date in Private Exchange Offers and Consent Solicitations for EIDP's 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033 - Eastern Progress
Meeder Advisory Services Inc. Takes Position in Corteva, Inc. $CTVA - MarketBeat
Wealthfront Advisers LLC Buys New Position in Corteva, Inc. $CTVA - MarketBeat
Great Lakes Advisors LLC Purchases Shares of 61,037 Corteva, Inc. $CTVA - MarketBeat
Bell & Brown Wealth Advisors LLC Acquires Shares of 14,533 Corteva, Inc. $CTVA - MarketBeat
Oxbow Advisors LLC Makes New $8.16 Million Investment in Corteva, Inc. $CTVA - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Purchases New Stake in Corteva, Inc. $CTVA - MarketBeat
Perigon Wealth Management LLC Makes New Investment in Corteva, Inc. $CTVA - MarketBeat
Danske Bank A S Buys New Stake in Corteva, Inc. $CTVA - MarketBeat
17,370 Shares in Corteva, Inc. $CTVA Purchased by Citizens Financial Group Inc. RI - MarketBeat
Deutsche Bank AG Invests $250.47 Million in Corteva, Inc. $CTVA - MarketBeat
53,845,550 Shares in Corteva, Inc. $CTVA Purchased by BlackRock Inc. - MarketBeat
UBS cuts Corteva stock price target to $85 on 2027 growth outlook - Investing.com Australia
Corteva's settlement with Arkansas over crop protection chemicals gets initial nod - MLex
Corteva sued by herbicide supplier over alleged US monopolization scheme - MLex
CTVA Looks 16.6% Overvalued on GF Value™ Amid Mixed Guru and Ins - GuruFocus
CTVA Maintained by UBS -- Price Target Lowered to $85.00 - GuruFocus
UBS raises Corteva profit forecasts ahead of planned split (CTVA:NYSE) - Seeking Alpha
Corteva (CTVA) Stock May Be 32% Undervalued After Debt Exchange Offers - Yahoo Finance
UBS Adjusts Price Target on Corteva to $85 From $89, Maintains Neutral Rating - marketscreener.com
MidFirst Bank Acquires New Holdings in Corteva, Inc. $CTVA - MarketBeat
Pallas Capital Advisors LLC Takes $4.72 Million Position in Corteva, Inc. $CTVA - MarketBeat
Trust Co. of Vermont Makes New $8.42 Million Investment in Corteva, Inc. $CTVA - MarketBeat
Can Strategic Investments Boost Mission Produce's Returns? - TradingView
38,546 Shares in Corteva, Inc. $CTVA Acquired by Plato Investment Management Ltd - MarketBeat
1ST Source Bank Invests $1.61 Million in Corteva, Inc. $CTVA - MarketBeat
Corteva Inc (CTVA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Corteva Subsidiary Files Amended Form 10 for Seed Business Spin-Off - Minichart
Corteva Advances Vylor Seed Business Spin-Off with First Registration Amendment - Kalkine Media
Corteva (CTVA) Files Form 8-K Detailing Planned Spin-Off and Ass - GuruFocus
Corteva To Pay $3.1M In Ark. AG's Pesticides Antitrust Suit - Law360
Q2 2026 Corteva Inc Earnings Call Transcript - GuruFocus
Form 8K Corteva Inc For: 14 August By Investing.com - Investing.com Australia
Corteva files amendment for Vylor seed business spin-off with SEC - Investing.com Australia
Corteva files amendment for Vylor spin-off registration statement - Investing.com
Corteva files amendment for Vylor spin-off registration statement By Investing.com - Investing.com India
AVIP BlackRock Balanced Allocation Portfolio's Corteva Inc(CTVA) Holding History - GuruFocus
Corteva, Inc.: Target Price Consensus and Analysts Recommendations | 2X0 | US22052L1044 - marketscreener.com
Microbial Inoculants & N-Fixing Microbes Market Report 2026–2035: Evaluating $6.7 Billion Forecast, Liquid Formulations, and Strategies of Novonesis, BASF, Corteva, and Bioceres - Yahoo Finance UK
Renaissance Technologies LLC Makes New Investment in Corteva, Inc. $CTVA - MarketBeat
Promising Agriculture Stocks To Follow TodayAugust 13th - MarketBeat
Judge in Inari-Corteva Suit Wants Answers About Sponsored Ad - Bloomberg Law News
Finanzdaten der Corteva Inc-Aktie (CTVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.94%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):